220 related articles for article (PubMed ID: 12131018)
1. Relationship of C-reactive protein to presence and severity of coronary atherosclerosis in patients with stable angina pectoris or a pathological exercise test.
Veselka J; Procházková S; Duchonová R; Bolomová I; Urbanová T; Tesar D; Honek T
Coron Artery Dis; 2002 May; 13(3):151-4. PubMed ID: 12131018
[TBL] [Abstract][Full Text] [Related]
2. Relationship of C-reactive protein to adverse cardiovascular events in patients treated by percutaneous coronary intervention for stable angina pectoris.
Veselka J; Procházková S; Duchonová R; Homolová I; Tesar D
Int Heart J; 2005 Mar; 46(2):195-204. PubMed ID: 15876803
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction.
Zebrack JS; Anderson JL; Maycock CA; Horne BD; Bair TL; Muhlestein JB;
Am J Cardiol; 2002 Jan; 89(2):145-9. PubMed ID: 11792332
[TBL] [Abstract][Full Text] [Related]
4. Serum pentraxin 3 levels are associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris.
Karakas MF; Buyukkaya E; Kurt M; Motor S; Akcay AB; Buyukkaya S; Karakas E; Bilen P; Sen N
J Investig Med; 2013 Feb; 61(2):278-85. PubMed ID: 23237880
[TBL] [Abstract][Full Text] [Related]
5. [The relationship between serum C-reactive protein levels and coronary artery disease in patients with stable angina pectoris and positive exercise stress test].
Türkoğlu EI; Gürgün C; Zoghi M; Türkoğlu C
Anadolu Kardiyol Derg; 2004 Sep; 4(3):199-202. PubMed ID: 15355818
[TBL] [Abstract][Full Text] [Related]
6. Comparison of silent and symptomatic ischemia during exercise testing in men.
Miranda CP; Lehmann KG; Lachterman B; Coodley EM; Froelicher VF
Ann Intern Med; 1991 Apr; 114(8):649-56. PubMed ID: 2003711
[TBL] [Abstract][Full Text] [Related]
7. Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease.
Hung MJ; Cherng WJ; Cheng CW; Li LF
Am J Cardiol; 2006 May; 97(10):1429-34. PubMed ID: 16679078
[TBL] [Abstract][Full Text] [Related]
8. Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions.
Zhang B; Peng W; Li H; Lu Y; Zhuang J; Wang K; Su Y; Xu Y
Clin Biochem; 2013 Oct; 46(15):1520-5. PubMed ID: 23850850
[TBL] [Abstract][Full Text] [Related]
9. High-sensitivity C-reactive protein may be an indicator of the development of atherosclerosis in myocardial bridging.
Duygu H; Zoghi M; Nalbantgil S; Ozerkan F; Cakir C; Ertas F; Yuksek U; Akilli A; Akin M; Ergene O
Int J Cardiol; 2008 Feb; 124(2):267-70. PubMed ID: 17395309
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein in unstable angina pectoris and its relation to coronary angiographic severity and diffusion scores of coronary lesions.
Soysal D; Karakuş V; Yavaş HH; Biçeroğlu S; Köseoğlu M; Yeşil M
Anadolu Kardiyol Derg; 2010 Oct; 10(5):421-8. PubMed ID: 20929699
[TBL] [Abstract][Full Text] [Related]
11. Effect of obesity on the relationship between plasma C-reactive protein and coronary artery stenosis in patients with stable angina.
Aronson D; Goldberg A; Roguin A; Petcherski S; Rimer D; Gruberg L; Avizohar O; Levy Y; Markiewicz W; Beyar R
Atherosclerosis; 2006 Mar; 185(1):137-42. PubMed ID: 16024024
[TBL] [Abstract][Full Text] [Related]
12. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
Haverkate F; Thompson SG; Pyke SD; Gallimore JR; Pepys MB
Lancet; 1997 Feb; 349(9050):462-6. PubMed ID: 9040576
[TBL] [Abstract][Full Text] [Related]
13. Multiple complex stenoses, high neutrophil count and C-reactive protein levels in patients with chronic stable angina.
Avanzas P; Arroyo-Espliguero R; Cosín-Sales J; Quiles J; Zouridakis E; Kaski JC
Atherosclerosis; 2004 Jul; 175(1):151-7. PubMed ID: 15186960
[TBL] [Abstract][Full Text] [Related]
14. High-sensitivity C-reactive protein and plaque composition in patients with stable angina pectoris: a virtual histology intravascular ultrasound study.
Kubo T; Matsuo Y; Hayashi Y; Yamano T; Tanimoto T; Ino Y; Kitabata H; Takarada S; Hirata K; Tanaka A; Nakamura N; Mizukoshi M; Imanishi T; Akasaka T
Coron Artery Dis; 2009 Dec; 20(8):531-5. PubMed ID: 19855269
[TBL] [Abstract][Full Text] [Related]
15. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudy.
Sabatine MS; Morrow DA; Cannon CP; Murphy SA; Demopoulos LA; DiBattiste PM; McCabe CH; Braunwald E; Gibson CM
J Am Coll Cardiol; 2002 Nov; 40(10):1761-8. PubMed ID: 12446059
[TBL] [Abstract][Full Text] [Related]
16. Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting.
Inoue T; Kato T; Uchida T; Sakuma M; Nakajima A; Shibazaki M; Imoto Y; Saito M; Hashimoto S; Hikichi Y; Node K
J Am Coll Cardiol; 2005 Jul; 46(2):239-45. PubMed ID: 16022949
[TBL] [Abstract][Full Text] [Related]
17. Relation of C-reactive protein to coronary collaterals in patients with stable angina pectoris and coronary artery disease.
Kerner A; Gruberg L; Goldberg A; Roguin A; Lavie P; Lavie L; Markiewicz W; Beyar R; Aronson D
Am J Cardiol; 2007 Feb; 99(4):509-12. PubMed ID: 17293195
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein as a marker for active coronary artery disease in patients with chest pain in the emergency room.
Magadle R; Weiner P; Beckerman M; Berar-Yanay N
Clin Cardiol; 2002 Oct; 25(10):456-60. PubMed ID: 12375803
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina.
Zebrack JS; Muhlestein JB; Horne BD; Anderson JL;
J Am Coll Cardiol; 2002 Feb; 39(4):632-7. PubMed ID: 11849862
[TBL] [Abstract][Full Text] [Related]
20. Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction.
Meuwissen M; van der Wal AC; Niessen HW; Koch KT; de Winter RJ; van der Loos CM; Rittersma SZ; Chamuleau SA; Tijssen JG; Becker AE; Piek JJ
J Clin Pathol; 2006 Feb; 59(2):196-201. PubMed ID: 16443738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
